– Reuters
IGC Pharma FY23 Revenue Grows 129%, What About Net Loss?
IGC Pharma, Inc. (AMEX:IGC) released its financial results for the fiscal year ended March 31, 2023, revealing revenue of $911,000, an increase of 129% compared to $397,000 in fiscal year 2022.
FY 2023 Financial Highlights